rs556646437

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_005076.5(CNTN2):​c.1786G>A​(p.Ala596Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000451 in 1,598,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A596V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000047 ( 0 hom. )

Consequence

CNTN2
NM_005076.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 3.69

Publications

0 publications found
Variant links:
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial adult myoclonic, 5
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019926041).
BP6
Variant 1-205065879-G-A is Benign according to our data. Variant chr1-205065879-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 474468.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000267 (4/150034) while in subpopulation SAS AF = 0.000838 (4/4772). AF 95% confidence interval is 0.000286. There are 0 homozygotes in GnomAd4. There are 1 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005076.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTN2
NM_005076.5
MANE Select
c.1786G>Ap.Ala596Thr
missense
Exon 14 of 23NP_005067.1Q02246
CNTN2
NM_001346083.2
c.1786G>Ap.Ala596Thr
missense
Exon 14 of 23NP_001333012.1Q02246
CNTN2
NR_144350.2
n.2055G>A
non_coding_transcript_exon
Exon 14 of 23

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTN2
ENST00000331830.7
TSL:1 MANE Select
c.1786G>Ap.Ala596Thr
missense
Exon 14 of 23ENSP00000330633.4Q02246
CNTN2
ENST00000640428.1
TSL:5
c.1786G>Ap.Ala596Thr
missense
Exon 14 of 23ENSP00000491474.1A0A1W2PQ11
CNTN2
ENST00000853779.1
c.1837G>Ap.Ala613Thr
missense
Exon 15 of 24ENSP00000523838.1

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
4
AN:
149916
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000838
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000918
AC:
23
AN:
250422
AF XY:
0.0000887
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000885
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000470
AC:
68
AN:
1448036
Hom.:
0
Cov.:
34
AF XY:
0.0000527
AC XY:
38
AN XY:
720758
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33364
American (AMR)
AF:
0.00
AC:
0
AN:
44082
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25790
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39632
South Asian (SAS)
AF:
0.000513
AC:
44
AN:
85718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000109
AC:
12
AN:
1101796
Other (OTH)
AF:
0.000202
AC:
12
AN:
59516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000267
AC:
4
AN:
150034
Hom.:
0
Cov.:
32
AF XY:
0.0000136
AC XY:
1
AN XY:
73306
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41222
American (AMR)
AF:
0.00
AC:
0
AN:
15010
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3424
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.000838
AC:
4
AN:
4772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10246
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66964
Other (OTH)
AF:
0.00
AC:
0
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000812
Hom.:
0
Bravo
AF:
0.0000189
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000107
AC:
13
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Epilepsy, familial adult myoclonic, 5 (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.099
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.26
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.77
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.020
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.92
L
PhyloP100
3.7
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.045
Sift
Benign
0.43
T
Sift4G
Benign
0.50
T
Polyphen
0.0040
B
Vest4
0.32
MutPred
0.47
Gain of phosphorylation at A596 (P = 0.0169)
MVP
0.76
MPC
0.43
ClinPred
0.052
T
GERP RS
3.5
PromoterAI
0.034
Neutral
Varity_R
0.051
gMVP
0.25
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs556646437; hg19: chr1-205035007; COSMIC: COSV100084861; COSMIC: COSV100084861; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.